Research & News

HIV and Mode of Delivery

Dec 31, 2015

An analysis of mode of delivery for HIV-infected women in Philadelphia between 2005-2013 found that a large number of women were not receiving a scheduled c-section for maternal viral load >1,000 copies/ml as recommended by the guidelines. Hispanic women and non-... Read More

PrEP in Clinical Setting Results in No New HIV Infections

Dec 30, 2015

In a large clinical practice setting, there has been an increasing amount of referrals and initiation of preexposure prophylaxis (PrEP) for the prevention of HIV transmission. In this particular group over a three year period, there were no new cases of HIV among those... Read More

HIV Medications and Hormonal Contraceptives

Dec 30, 2015

The Partners in Prevention HSVHIV Transmission Study and Partners in PrEP Study researchers looked at the effectiveness of hormonal contraceptives in preventing pregnancy for those women on antiretroviral therapy. They found that ART did not significantly diminish the... Read More

Do Financial Incentives Increase HIV Care Engagement and Retention?

Oct 23, 2015

Successful HIV care involves getting tested, initiating care, remaining in care, and taking ARVs as needed. Movement through the HIV care cascade may be helped by the use of financial incentives that reward patients for completing steps in the cascade. Researchers... Read More

Prevention of Perinatal HIV Case Review

Oct 23, 2015

Researchers in Georgia completed a case review of HIV-infected infants born between 2005-2012 for risk factors associated with mother-to-child transmission of HIV. Of the 27 cases identified, 53% of mothers did not receive ARVs during pregnancy or labor. Additionally,... Read More

WHO Guidelines on PrEP and Initiation of ARVs for HIV

Sep 15, 2015

The World Health Organization released its Guideline on When to Start Antiretroviral Therapy and on Pre-Exposure Prophylaxis for HIV as a early release in preparation for updating its guidelines on the use of antiretroviral therapy for treating and preventing HIV which is... Read More

Hormonal Contraception and Interactions with ARVs

Sep 01, 2015

Publications and pharmaceutical packages were reviewed to determine any contraindications for ARV co-administration with hormonal contraceptive methods (oral contraceptive pills, injectable dept medroxyprogesterone acetate [DMPA], levonorgestrel intrauterine system [LNG-... Read More

Updated Perinatal Guidelines Now Available

Aug 13, 2015

The HHS Panel on Treatment of HIV-Infected Pregnant Women and Prevention of Perinatal Transmission announced the release of the updated Recommendations for Use of Antiretroviral Drugs in Pregnant HIV-1-Infected Women for Maternal Health and Interventions to Reduce... Read More

HIV Viral Load During Pregnancy Impacted by Time of Diagnosis and Prenatal Care

Jul 28, 2015

A retrospective review of HIV-positive women who delivered in Philadelphia between 2005-2013 found that women who were diagnosed HIV-positive during pregnancy were less likely to receive antiretroviral therapy and have an undetectable viral load than those diagnosed prior... Read More

FDA Approves Test to Distinguish Type of HIV Infection

Jul 28, 2015

The BioPlex 2200 HIV Ag-Ab assay has been approved by the FDA for use in distinguishing between HIV-1 antibodies, HIV-2 antibodies and the HIV-1 p24 antigen.This is approved for use in pregnant women and is another tool to aid in prevention of perinatal transmission... Read More

Pages